Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Rheumatoid Arthritis”

263 trials

Showing 20 of 263 results

Large-scale testing (Phase 3)Study completedNCT01213017
What this trial is testing

The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Oklahoma Medical Research Foundation 20
Early research (Phase 1)Looking for participantsNCT07207954
What this trial is testing

Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lifordi Immunotherapeutics, Inc. 176
Large-scale testing (Phase 3)Study completedNCT01970475
What this trial is testing

Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Amgen 526
Testing effectiveness (Phase 2)UnknownNCT06306339
What this trial is testing

Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug)

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
ImmuneMed, Inc. 60
Not applicableUnknownNCT04134169
What this trial is testing

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

Who this might be right for
Rheumatoid Arthritis
Kang Stem Biotech Co., Ltd. 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Testing effectiveness (Phase 2)Study completedNCT01369745
What this trial is testing

A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Zalicus 294
Testing effectiveness (Phase 2)Ended earlyNCT02882087
What this trial is testing

The Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis

Who this might be right for
Moderate and Severe Rheumatoid Arthritis
RemeGen Co., Ltd. 60
Post-approval studies (Phase 4)Ended earlyNCT01283971
What this trial is testing

RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 96
Large-scale testing (Phase 3)Study completedNCT01721057
What this trial is testing

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 684
Large-scale testing (Phase 3)Study completedNCT04512001
What this trial is testing

MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 604
Testing effectiveness (Phase 2)Study completedNCT04049448
What this trial is testing

Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abivax S.A. 40
Large-scale testing (Phase 3)Study completedNCT00535782
What this trial is testing

The Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 132
Post-approval studies (Phase 4)Study completedNCT01255761
What this trial is testing

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 736
Early research (Phase 1)Study completedNCT04911127
What this trial is testing

Therapeutic Response of Cannabidiol in Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisCannabis
University of California, Los Angeles 67
Post-approval studies (Phase 4)Study completedNCT00848354
What this trial is testing

Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

Who this might be right for
Rheumatoid Arthritis
Pfizer 429
Large-scale testing (Phase 3)Study completedNCT01347983
What this trial is testing

Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Chugai Pharma Taiwan 72
Testing effectiveness (Phase 2)Study completedNCT00425932
What this trial is testing

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Gaylis, Norman B., M.D. 60
Testing effectiveness (Phase 2)WithdrawnNCT05217472
What this trial is testing

An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)

Who this might be right for
Sjogren's Syndrome (SS)
AbbVie
Testing effectiveness (Phase 2)Study completedNCT06099535
What this trial is testing

LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 156
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation